ABOUT US

We were founded to provide novel treatments to patients suffering from severe autoinflammatory and autoimmune diseases with high medical need. The need to cure drives our team.

We aim to deliver a cure to patients that suffer from severe illness caused by an imbalanced immune system. We strive to develop novel, first-in-class therapies that can be manufactured with significantly higher efficiency and lower costs than comparable approaches.

Management

Our founders are experts in cell therapy with deep expertise and a specific knowhow in Treg biology

Andrea Tüttenberg,
MD

Chief Executive Officer/ Managing Director
Chief Medical Officer
Co-Founder

Helmut Jonuleit,
PhD

Chief Scientific Officer
Co-Founder

Franz-Joseph Schneider,
PhD

Chief Knowledge Officer
Co-Founder

Michael Kring

Chief Financial Officer,
Managing Director High Tech Corporate Services,
Co-Founder

Advisory Board

Frank Mühlenbeck,
MD

Senior Investment Manager
LBBW Venture Capital

Philipp Große,
PhD

Managing Director
MediVentures GmbH

Natalya Baltrukovich,
PhD

Senior Investment Manager
High-Tech Gründerfonds

Cornelius Sobel,
PhD

Managing Director
SPC GmbH

Caroline Lehmann,
PhD

LBBW
Venture Capital

Klaus Maleck,
PhD, MBA

Isotope Technologies Munich SE

INVESTORS

Founded in 1998, LBBW Venture Capital is the venture arm of Landesbank Baden-Württemberg based in Stuttgart, Germany. The firm focuses on investing in companies operating in the software, life science, healthcare technology and technology sectors.

Founded in 2005, High-Tech Gründerfonds is a venture capital firm based in Bonn, Germany. The firm seeks to invest in industrial technology, digital technology, life sciences, and chemical sector firms based in Germany.

WFT – a subsidiary of the Investment and Structural Bank of Rhineland-Palatinate (ISB) – provides venture capital at attractive conditions and, by broadening its liability capital base, enables newly founded companies to develop and market innovative products and production processes. In addition to financial support, the WFT also provides qualified support for the start-ups in the areas of controlling and marketing.

Founded in 2019, MediVentures is a venture capital firm based in Munich, Germany. The firm seeks to invest in life science and healthcare companies with a focus on diagnostics, therapies, and integrated care solutions.